PRM validation of 9 proteins that were highly expressed in the drug metabolism pathway further confirmed significant upregulation of MPO (17.05), TYMP (2.44), and IMPDH2 (1.78) in psoriasis lesions. This evidence concerns the gene TYMP and psoriasis.